MHRA (UK)
OTHER
Class 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45
Published: 10/29/2026Detected: 10/29/2026
Summary preview
Initiates a Class 2 medicines recall by Accord-UK Ltd for a single batch of lercanidipine hydrochloride 10 mg film-coated tablets due to a packaging mix-up that could result in patients receiving an incorrect strength.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountcardiology
safety
labeling
quality
#MHRA
#Class 2 recall
#lercanidipine
#incorrect strength
#packaging mix-up
Official Source Document Source Verified
Access the original document directly from MHRA.
More from MHRA (UK)
- Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/4410/29/2026
- Field Safety Notices: 19 to 23 October 202610/28/2026
- MHRA Safety Roundup: October 202610/27/2026
- Class 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/4310/26/2026
- Field Safety Notices: 5 to 9 October 202610/19/2026